Resveratrol
- Generic Name
- Resveratrol
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C14H12O3
- CAS Number
- 501-36-0
- Unique Ingredient Identifier
- Q369O8926L
- Background
Resveratrol (3,5,4'-trihydroxystilbene) is a polyphenolic phytoalexin. It is a stilbenoid, a derivate of stilbene, and is produced in plants with the help of the enzyme stilbene synthase. It exists as cis-(Z) and trans-(E) isomers. The trans- form can undergo isomerisation to the cis- form when heated or exposed to ultraviolet irradiation. In a 2004 issue of...
- Indication
Being investigated for the treatment of Herpes labialis infections (cold sores).
- Associated Conditions
- -
- Associated Therapies
- -
Improving Cardiovascular Health in Patients With Chronic Obstructive Pulmonary Disease
- Conditions
- Interventions
- First Posted Date
- 2019-01-28
- Last Posted Date
- 2024-04-29
- Lead Sponsor
- Virginia Commonwealth University
- Target Recruit Count
- 26
- Registration Number
- NCT03819517
- Locations
- 🇺🇸
Virginia Commonwealth University, Richmond, Virginia, United States
Nicotinamide Riboside With and Without Resveratrol to Improve Functioning in Peripheral Artery Disease
- Conditions
- Interventions
- First Posted Date
- 2018-11-16
- Last Posted Date
- 2023-06-26
- Lead Sponsor
- Northwestern University
- Target Recruit Count
- 90
- Registration Number
- NCT03743636
- Locations
- 🇺🇸
Northwestern University, Chicago, Illinois, United States
Multimodal Investigation of the Neuroprotective Effects of Resveratrol (MINER)
- First Posted Date
- 2018-09-11
- Last Posted Date
- 2018-09-11
- Lead Sponsor
- VISN 17 Center of Excellence
- Target Recruit Count
- 68
- Registration Number
- NCT03665740
- Locations
- 🇺🇸
VISN 17 Center of Excellence for Research on Returning War Veterans, Waco, Texas, United States
Evaluating the Clinical Efficacy of Resveratrol in Improving Metabolic and Skeletal Muscle Function in Patients With Heart Failure
- Conditions
- Interventions
- First Posted Date
- 2018-05-15
- Last Posted Date
- 2023-01-12
- Lead Sponsor
- University of Alberta
- Target Recruit Count
- 13
- Registration Number
- NCT03525379
- Locations
- 🇨🇦
Alberta Cardiovascular and Stroke Research Centre, Edmonton, Alberta, Canada
Resveratrol as a Preventive Treatment of OHSS
- First Posted Date
- 2018-02-27
- Last Posted Date
- 2019-08-20
- Lead Sponsor
- IVI Madrid
- Target Recruit Count
- 70
- Registration Number
- NCT03446625
- Locations
- 🇪🇸
Ivi Madrid, Madrid, Spain
Resveratrol and Sirolimus in Lymphangioleiomyomatosis Trial
- First Posted Date
- 2017-08-18
- Last Posted Date
- 2023-02-01
- Lead Sponsor
- University of Cincinnati
- Target Recruit Count
- 25
- Registration Number
- NCT03253913
- Locations
- 🇺🇸
University of Cincinnati, Cincinnati, Ohio, United States
Oral Resveratrol to Prevent Post-ERCP Pancreatitis
- Conditions
- Interventions
- First Posted Date
- 2016-10-28
- Last Posted Date
- 2016-10-28
- Target Recruit Count
- 2700
- Registration Number
- NCT02947932
Resveratrol's Effects in Diabetic Nephropathy
- Conditions
- Interventions
- First Posted Date
- 2016-03-10
- Last Posted Date
- 2017-10-05
- Lead Sponsor
- Shiraz University of Medical Sciences
- Target Recruit Count
- 60
- Registration Number
- NCT02704494
- Locations
- 🇮🇷
Shahid Motahhari Clinic, Shiraz University of Medical Sciences, Shiraz, Fars, Iran, Islamic Republic of
Effect of Administration of Resveratrol on Glycemic Variability in Individuals With Type 2 Diabetes Mellitus
- First Posted Date
- 2015-09-15
- Last Posted Date
- 2018-05-08
- Lead Sponsor
- University of Guadalajara
- Target Recruit Count
- 22
- Registration Number
- NCT02549924
- Locations
- 🇲🇽
Institute of Experimental and Clinical Therapeutics (INTEC), CUCS, University of Guadalajara, Guadalajara, Jalisco, Mexico
Resveratrol and Exercise to Treat Functional Limitations in Late Life
- First Posted Date
- 2015-08-14
- Last Posted Date
- 2022-01-13
- Lead Sponsor
- University of Florida
- Target Recruit Count
- 60
- Registration Number
- NCT02523274
- Locations
- 🇺🇸
UAB Center for Exercise Medicine, Birmingham, Alabama, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.